Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Alterity Therapeutics stock
Learn how to easily invest in Alterity Therapeutics stock.
Alterity Therapeutics Ltd is a biotechnology business based in the US. Alterity Therapeutics shares (ATHE) are listed on the NASDAQ and all prices are listed in US Dollars. Alterity Therapeutics employs 12 staff and has a trailing 12-month revenue of around $5.1 million.
How to buy shares in Alterity Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ATHE – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Alterity Therapeutics stock price (NASDAQ: ATHE)Use our graph to track the performance of ATHE stocks over time.
Alterity Therapeutics shares at a glance
|Latest market close||$0.45|
|52-week range||$0.40 - $1.38|
|50-day moving average||$0.59|
|200-day moving average||$0.72|
|Wall St. target price||$3.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.24|
Buy Alterity Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Alterity Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Alterity Therapeutics price performance over time
|1 week (2022-09-19)||-19.64%|
|1 month (2022-08-26)||-25.00%|
|3 months (2022-06-29)||-29.75%|
|6 months (2022-03-28)||-43.04%|
|1 year (2021-09-29)||-64.29%|
|2 years (2020-09-29)||-78.67%|
|3 years (2019-09-27)||1.19|
|5 years (2017-09-29)||2.8|
Alterity Therapeutics financials
|Revenue TTM||$5.1 million|
|Gross profit TTM||$4.8 million|
|Return on assets TTM||-25.85%|
|Return on equity TTM||-38.97%|
|Market capitalisation||$22.1 million|
TTM: trailing 12 months
Alterity Therapeutics share dividends
We're not expecting Alterity Therapeutics to pay a dividend over the next 12 months.
Have Alterity Therapeutics's shares ever split?
Alterity Therapeutics's shares were split on a 1:6 basis on 23 March 2016. So if you had owned 6 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Alterity Therapeutics shares – just the quantity. However, indirectly, the new 500% higher share price could have impacted the market appetite for Alterity Therapeutics shares which in turn could have impacted Alterity Therapeutics's share price.
Alterity Therapeutics share price volatility
Over the last 12 months, Alterity Therapeutics's shares have ranged in value from as little as $0.4 up to $1.38. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Alterity Therapeutics's is 1.0288. This would suggest that Alterity Therapeutics's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Alterity Therapeutics overview
Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing PBT2 that has completed Phase 2a clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia. .
Frequently asked questionsWhat percentage of Alterity Therapeutics is owned by institutions?
Currently 1.809% of Alterity Therapeutics shares are held by institutions. How many people work for Alterity Therapeutics?
Latest data suggests 12 work at Alterity Therapeutics. When does the fiscal year end for Alterity Therapeutics?
Alterity Therapeutics's fiscal year ends in June. Where is Alterity Therapeutics based?
Alterity Therapeutics's address is: 460 Bourke Street, Melbourne, VIC, Australia, 3000 What is Alterity Therapeutics's ISIN number?
Alterity Therapeutics's international securities identification number is: US02155X1063 What is Alterity Therapeutics's CUSIP number?
Alterity Therapeutics's Committee on Uniform Securities Identification Procedures number is: 02155X106
More guides on Finder
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
We’ve rounded up stats on some of the most popular wheat stocks, along with information on how these stocks compare and how to invest.
Ask an Expert